[1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest. 2004;34:392-401]Search in Google Scholar
[2. Boilard E, Nigrovic PA, Larabee K, Watts GFM, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen dependent microparticle production. Science. 2010; 327(5965): 580-310.1126/science.1181928292786120110505]Search in Google Scholar
[3. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9:581-9310.1038/nri256719498381]Search in Google Scholar
[4. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106:1604-1110.1182/blood-2004-03-109515741221]Search in Google Scholar
[5. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry. 2010; 77A (6):502-1410.1002/cyto.a.20886291989420235276]Search in Google Scholar
[6. Nieuwland R, Sturk A. Why do cells release vesicles?. Thromb Res. 2010 Feb; 125: S49-5110.1016/j.thromres.2010.01.03720149923]Search in Google Scholar
[7. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008; 3:e369410.1371/journal.pone.0003694257789119002258]Search in Google Scholar
[8. Jonas R, Nilsson A, Balaj L, Hulleman E, van Rijn S, Pegtel DM, et al. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011; 118: 3680-310.1182/blood-2011-03-344408722463721832279]Search in Google Scholar
[9. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012; 64(3): 676-70510.1124/pr.112.00598322722893]Search in Google Scholar
[10. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8:2358-6810.1111/j.1538-7836.2010.04007.x20695980]Search in Google Scholar
[11. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood. 2008; 111: 5028-3610.1182/blood-2007-06-097410238413118198347]Search in Google Scholar
[12. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20:1-2610.1016/j.tmrv.2005.08.001]Search in Google Scholar
[13. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009; 114: 723-3210.1182/blood-2009-02-205930]Search in Google Scholar
[14. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009; 8: 2014-1810.4161/cc.8.13.8988]Search in Google Scholar
[15. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009; 101:439-5110.1160/TH08-08-0521]Search in Google Scholar
[16. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13: 269-8810.1111/j.1365-2141.1967.tb08741.x]Search in Google Scholar
[17. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30: 111-4210.1016/S1040-8428(98)00044-4]Search in Google Scholar
[18. Dignat George F. Microparticles in vascular diseases. Thromb Res 2008; 122; Suppl 1, S55-910.1016/S0049-3848(08)70020-3]Search in Google Scholar
[19. Ye R, Ye C, Huang Y, Liu L, Wang S. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. 2012; 130:253-8]Search in Google Scholar
[20. Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res. 2010;125(Suppl 1): S46-810.1016/j.thromres.2010.01.036]Search in Google Scholar
[21. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol. 2010; 26(4): e140-e14510.1016/S0828-282X(10)70371-8]Search in Google Scholar
[22. Flaumenhaft R, Dilks JR, Richardson, Alden E, Patel-Hett SR, Battinelli E, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood. 2009; 113:1112-2110.1182/blood-2008-06-163832263507618802008]Search in Google Scholar
[23. Dasgupta SK, Le A, Chavakis, Rumbaut RE, Thiagarajan P. Developmental Endothelial Locus-1 (Del-1) mediates clearance of platelet microparticles by the Endothelium. Circulation. 2012; 125 (13): 1664-7210.1161/CIRCULATIONAHA.111.068833]Search in Google Scholar
[24. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost. 2010; 8(11):2358-6810.1111/j.1538-7836.2010.04007.x]Search in Google Scholar
[25. Falanga A, Tartari CJ, Marchetti M. Microparticles in tumor progression. Thromb Res 2012; 129; Suppl 1, S132-610.1016/S0049-3848(12)70033-6]Search in Google Scholar
[26. Rak J. Microparticles in cancer. Semin Thromb Hemost. 2010; 36:888-90610.1055/s-0030-1267043]Search in Google Scholar
[27. Varon D, Hayon Y, Dashevsky O, Shai E. Involvment of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb Res 2012; 130: S98-910.1016/j.thromres.2012.08.289]Search in Google Scholar
[28. Castaman G, Yu-Feng L, Rodeghiero F. A bleeding disorder characterized by isolated deficiency of platelet microvesicle generation. Lancet 1996; 347:700-110.1016/S0140-6736(96)91259-3]Search in Google Scholar
[29. Castaman G, Yu-Feng L, Battistin E. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997; 96:458-6310.1046/j.1365-2141.1997.d01-2072.x9054648]Search in Google Scholar
[30. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004; 1636:119-2810.1016/j.bbalip.2003.07.00315164759]Search in Google Scholar
[31. Ahn YS. Cell-derived microparticles:‘Miniature envoys with many faces’. J Thromb Hemost 2005; 3:884-710.1111/j.1538-7836.2005.01347.x15869581]Search in Google Scholar
[32. Rank A, Nieuwland R, Delker R, Kohler A, Toth B, Pihusch V, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010; 126: e255-e25910.1016/j.thromres.2010.07.01220696467]Search in Google Scholar
[33. Lechner D, Weltermann A. Circulating tissue factorexposing microparticles. Thromb Res. 2008; 122 (Suppl.1):S47-5410.1016/S0049-3848(08)70019-7]Search in Google Scholar
[34. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97(3):425-3410.1160/TH06-06-0313]Search in Google Scholar
[35. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biró E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2:1842-310.1111/j.1538-7836.2004.00936.x]Search in Google Scholar
[36. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol. 2007 Dec; 7(12):964-7410.1038/nri2214]Search in Google Scholar
[37. Castellana D, Totti F, Freyssinet JM. Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res. 2010; 125 (Suppl 2):S84-810.1016/S0049-3848(10)70021-9]Search in Google Scholar
[38. Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res. 2011; 127(5):473-710.1016/j.thromres.2011.01.002]Search in Google Scholar
[39. Basavaraj MG, Olsen JO, Osterud B, Hansen JB. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res. 2012; 130:538-14 10.1016/j.thromres.2012.06.001]Search in Google Scholar
[40. Key NS. Analysis of tissue factor positive microparticles. Thromb Res. 2010; 125:S42-510.1016/j.thromres.2010.01.035]Search in Google Scholar
[41. Ruf W. Tissue factor and cancer. Thromb Res. 2012; S84-710.1016/j.thromres.2012.08.285]Search in Google Scholar
[42. Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res.2010; 125(Suppl.2):S89-9110.1016/S0049-3848(10)70022-0]Search in Google Scholar
[43. Chitlur M, Massicotte MP. The perfect measure of hemostasis: a quest for the holy grail. Thromb Res. 2010; 125(6): 481-210.1016/j.thromres.2009.08.022]Search in Google Scholar
[44. Favaloroa EJ, Lippi G. Coagulation update: what’s new in hemostasis testing? Thromb Res. 2011; 127; Suppl. 2 :S13-S610.1016/S0049-3848(10)70148-1]Search in Google Scholar
[45. Siljander PRM. Platelet-derived microparticles - an updated perspective. Thromb Res. 2011; 127:S30-310.1016/S0049-3848(10)70152-3]Search in Google Scholar
[46. Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang.2009; 96(3):206-1210.1111/j.1423-0410.2008.01151.x19175566]Search in Google Scholar
[47. Yuana Y, Oosterkamp TH, Bahatyrova S...Atomic force microscopy: a novel approach to the detection of nano-sized blood microparticles. J Thromb Haemost. 2010; 8(2):315-2310.1111/j.1538-7836.2009.03654.x19840362]Search in Google Scholar
[48. Gross PL, Vaezzadeh N. Tissue factor microparticles and haemophilia. Thromb Res.2010; 125:S67-910.1016/j.thromres.2010.01.04120171716]Search in Google Scholar
[49. Dignat-George F, Feyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets. 2009 ; 20(3):225-610.1080/0953710090279550019437341]Search in Google Scholar
[50. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res 2011; 127:370-710.1016/j.thromres.2010.12.01421257195]Search in Google Scholar
[51. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012; 10:437-4610.1111/j.1538-7836.2011.04610.x22212198]Search in Google Scholar
[52. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost. 2009; 7(1):190-7]Search in Google Scholar
[53. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R. Isotype controls in phenotyping and quantification of microparticles: A major source of error and how to evade it. Thromb Res 2008; 122:691-70010.1016/j.thromres.2008.01.00518304614]Search in Google Scholar
[54. György B, Módos K, Pállinger E, Pálóczi K, Pásztói M, Misják P et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 2011; 117(4):e39-4810.1182/blood-2010-09-30759521041717]Search in Google Scholar
[55. Williams JC, Mackman N. MPs or ICs? Blood. 2011; 117: 1101-2]Search in Google Scholar
[56. Mobarrez F, Antovic J, Egberg N, Hansson M, Jorneskog G, Hultenby K et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010; 125:e110-610.1016/j.thromres.2009.10.00619939440]Search in Google Scholar
[57. Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J. Red cell PMVs, plasma membrane-derived vesicles calling out for standards. Biochem Biophys Res Commun 2010; 399: 465-9 10.1016/j.bbrc.2010.07.09520674549]Search in Google Scholar